About STAQ Pharma
STAQ Pharma is a company based in Denver (United States) founded in 2018. STAQ Pharma has raised $33.52 million across 6 funding rounds from investors including University Hospitals, Cincinnati Children’s and LCMC Health. The company has 30 employees as of December 31, 2022. STAQ Pharma offers products and services including Sterile Medications and Oncology Portfolio. STAQ Pharma operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
- Headquarter Denver, United States
- Employees 30 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Staq
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$33.52 M (USD)
in 6 rounds
-
Latest Funding Round
$11.4 M (USD), Series D
Sep 04, 2024
-
Investors
University Hospitals
& 6 more
-
Employee Count
30
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of STAQ Pharma
STAQ Pharma offers a comprehensive portfolio of products and services, including Sterile Medications and Oncology Portfolio.
Compounded sterile drugs for hospital use in shortages.
Medications addressing cancer drug shortages reliably.
People of STAQ Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of STAQ Pharma
STAQ Pharma has successfully raised a total of $33.52M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $11.4 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $11.4M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series D - STAQ Pharma | Valuation |
investors |
|
| Apr, 2023 | Amount | Series C - STAQ Pharma | Valuation |
investors |
|
| Mar, 2022 | Amount | Series C - STAQ Pharma | Valuation | Froedtert Health , UNC Health |
Investors in STAQ Pharma
STAQ Pharma has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include University Hospitals, Cincinnati Children’s and LCMC Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startup Studio building companies in the US & Europe and Angel Network for Ohio based companies
|
Founded Year | Domain | Location | |
|
A comprehensive health system delivering quality medical care.
|
Founded Year | Domain | Location | |
|
Health systems
|
Founded Year | Domain | Location |
Investments & Acquisitions by STAQ Pharma
Financial Statements - STAQ Pharma
Staq Pharma Comparisons
Competitors of STAQ Pharma
STAQ Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Cancer and CVMD drugs are developed using PDX models.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided for therapeutic development.
|
|
| domain | founded_year | HQ Location |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery and development research services are provided.
|
Frequently Asked Questions about STAQ Pharma
STAQ Pharma was founded in 2018 and raised its 1st funding round 2 years after it was founded.
STAQ Pharma is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
STAQ Pharma is a funded company, having raised a total of $33.52M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at STAQ Pharma is 30.
STAQ Pharma was founded in 2018 and is headquartered in Denver, United States. Drug discovery services are offered within the pharmaceutical sector, supporting early-stage research and development processes. Operations encompass computational modeling, screening, and optimization techniques to aid in identifying potential therapeutic candidates. The focus remains on collaborative partnerships with biotech firms, ensuring efficient workflows from target identification to lead validation across the U.S. market.
STAQ Pharma's top competitors include Evotec, Crown Bioscience and NIH.
STAQ Pharma offers Sterile Medications and Oncology Portfolio.
STAQ Pharma has 7 investors. Key investors include University Hospitals, Cincinnati Children’s, LCMC Health, Nationwide Children's Hospital, and UNC Health.